Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes

Human Immunology

Volumn 73, Issue 6, 2012, Pages 636-640

  White, Sarah J ^a   Haralambieva, Iana H ^a   Ovsyannikova, Inna G ^a   Vierkant, Robert A ^a   O'Byrne, Megan M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4 RECEPTOR ALPHA; MEASLES MUMPS RUBELLA VACCINE; NEUTRALIZING ANTIBODY;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CHILD; DNA SEQUENCE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MEASLES; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; FEMALE; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-23; MALE; MEASLES; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-12; VACCINATION; YOUNG ADULT;

EID: 84861782518     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.03.015     Document Type: Article

References (30)

1. Personal Communication, Division of Viral Diseases, Epidemiology Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC); 2011.
2. Tan P.L., Jacobson R.M., Poland G.A., Jacobsen S.J., Pankratz V.S. Twin studies of immunogenicity - determining the genetic contribution to vaccine failure. Vaccine 2001, 19:2434-2439.
3. Poland G.A., Jacobson R.M. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. Arch Intern Med 1994, 154:1815-1820.
4. Poland G.A., Jacobson R.M., Thampy A.M., Colbourne S.A., Wollan P.C., Lipsky J.J., et al. Measles reimmunization in children seronegative after initial immunization. JAMA 1997, 277:1156-1158.
5. Keen L.J. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 2002, 10:143-146.
6. Griffin D.E. Immune responses during measles virus infection. Curr Top Microbiol Immunol 1995, 191:117-134.
7. Dhiman N., Ovsyannikova I.G., Ryan J.E., Jacobson R.M., Vierkant R.A., Pankratz V.S., et al. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin Exp Immunol 2005, 142:498-504.
8. Nason M. Patterns of immune response to a vaccine or virus as measured by intracellular cytokine staining in flow cytometry: hypothesis generation and comparison of groups. J Biopharm Stat 2006, 16:483-498.
9. Nohria A., Rubin R.H. Cytokines as potential vaccine adjuvants. Biotherapy 1994, 7:261-269.
10. Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., et al. Replicating genotype-phenotype associations. Nature 2007, 447:655-660. NCI-NHGRI Working Group on Replication in Association Studies.
11. Long A.D., Langley C.H. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. Genome Res 1999, 9:720-731.
12. Guey LT, Kravic J, Melander O, Burtt NP, Laramie JM, Lyssenko V, et al. Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants; 2011. doi: 10.1002/gepi.20572.
13. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., et al. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007, 195:21-29.
14. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Poland G.A. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004, 65:1506-1515.
15. Haralambieva I.H., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., et al. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol 2010, 71:383-391.
16. Haralambieva I.H., Ovsyannikova I.G., O'Byrne M., Pankratz V.S., Jacobson R.M., Poland G.A. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine 2011, 29:4485-4491.
17. Haralambieva I.H., Ovsyannikova I.G., Vierkant R.A., Poland G.A. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clin Vaccine Immunol 2008, 15:1054-1059.
18. Ryan J.E., Ovsyannikova I.G., Poland G.A. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. Methods Mol Biol 2005, 302:207-218.
19. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
20. Langrish C.L., McKenzie B.S., Wilson N.J., De Waal Malefyt R., Kastelein R.A., Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004, 202:96-105.
21. Schulz E.G., Mariani L., Radbruch A., Höfer T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. Immunity 2009, 30:673-683.
22. Awasthi A., Kuchroo V.K. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009, 21:489-498.
23. Lin Y., Slight S.R., Khader S.A. Th17 cytokines and vaccine-induced immunity. Semin Immunopathol. 2010, 32:79-90.
24. Ovsyannikova I.G., Jacobson R.M., Dhiman N., Vierkant R.A., Pankratz V.S., Poland G.A. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 2008, 121. e1091-9.
25. Baralle D., Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet 2005, 42:737-748.
26. Ward A.J., Cooper T.A. The pathobiology of splicing. J Pathol 2010, 220:152-163.
27. Singer C., Grossman I., Avidan N., Beckmann J.S., Pe'er I. Trick or treat: the effect of placebo on the power of pharmacogenetic association studies. Hum Genomics 2005, 2:28-38.
28. van der Meide P.H., Groenestein R.J., de Labie M.C., Heeney J., Pala P., Slaoui M. Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques. J Med Primatol 1995, 24:271-281.
29. Poland G.A., Ovsyannikova I.G., Kennedy R.B., Haralambieva I.H., Jacobson R.M. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. Omics 2011, 15:625-636.
30. Ovsyannikova I.G., Poland G.A. Vaccinomics: current findings, challenges and novel approaches for vaccine development. AAPS J 2011, 13:438-444.